Sterling Wu

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis

Amy Cutrell, Jonathan Schapiro, Carlo Federico Perno et al. · AIDS · 2021 · 201 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis

Johnny Peppers, Amy S. Paller, Tomoko Maeda‐Chubachi et al. · Journal of the American Academy of Dermatology · 2018 · 164 citations

Medicine, Dermatology, Pharmacotherapy +7

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Giuliano Rizzardini, Edgar T. Overton, Chloe Orkin et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 149 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of KEYNOTE-426.

Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · Journal of Clinical Oncology · 2023 · 77 citations

Medicine, Oncology, Pharmacology +17

Post-Marketing Safety Evaluation of a Tetanus Toxoid, Reduced Diphtheria Toxoid and 3-Component Acellular Pertussis Vaccine Administered to a Cohort of Adolescents in a United States Health Maintenance Organization

Nicola P. Klein, John Hansen, Edwin Lewis et al. · The Pediatric Infectious Disease Journal · 2010 · 38 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17